Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML)

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Flasshove M, Strumberg D, Ayscue L, Mitchell BS, Tirier C, Heit W, Seeber S, Schutte J . Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside Leukemia 1994 8: 780–785

    CAS  PubMed  Google Scholar 

  2. Owens JK, Shewach DS, Ullman B, Mitchell BS . Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene Cancer Res 1992 52: 2389–2393

    CAS  PubMed  Google Scholar 

  3. Kobayashi T, Kakihara T, Uchiyama M, Fukuda T, Kishi K, Shibata A . Low expression of the deoxycytidine kinase (dCK) gene in a 1-beta-D-arabinofuranosylcytosine-resistant human leukemic cell line KY-Ra Leuk Lymphoma 1994 15: 503–505

    Article  CAS  PubMed  Google Scholar 

  4. Stammler G, Zintl F, Sauerbrey A, Volm M . Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia Anticancer Drugs 1997 8: 517–521

    Article  CAS  PubMed  Google Scholar 

  5. Kakihara T, Fukuda T, Tanaka A, Emura I, Kishi K, Asami K, Uchiyama M . Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia Leuk Lymphoma 1998 31: 405–409

    Article  CAS  PubMed  Google Scholar 

  6. Martincic D, Kravtsow V, Koury M, Avramis VI, Whitlock J . Deoxycytidine kinase expression and activity in ara-C resistant cell lines and samples from newly diagnosed acute leukemias Blood 1997 90: (Suppl. 1) 566a

    Google Scholar 

  7. Veuger MJ, Honders MW, Landegent JE, Willemze R, Barge RM . A novel RT-PCR-based protein activity truncation assay for direct assessment of deoxycytidine kinase in small numbers of purified leukemic cells Leukemia 2000 14: 1678–1684

    Article  CAS  PubMed  Google Scholar 

  8. Veuger MJ, Honders MW, Landegent JE, Willemze R, Barge RM . High incidence of alternatively spliced forms of deoxycytidinekinase in patients with resistant acute myeloid leukemia Blood 2000 96: 1517–1524

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by the Sophia Foundation for Medical Research (SSWO grant 246), the Foundation Pediatric Oncology Center Rotterdam (Stichting SKOR), and the Kröger Society. The contribution of three bone marrow samples from pediatric AML patients from the Dutch Childhood Leukemia Study Group is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

van den Heuvel-Eibrink, M., Wiemer, E., Kuijpers, M. et al. Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML). Leukemia 15, 855–856 (2001). https://doi.org/10.1038/sj.leu.2402112

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402112

This article is cited by

Search

Quick links